Alterations of tumor microenvironment by carbon monoxide impedes lung cancer growth

Oncotarget

Volumn 7, Issue 17, 2016, Pages 23919-23932

  Nemeth, Zsuzsanna ^a,b   Csizmadia, Eva ^a   Vikstrom, Lisa ^a   Li, Mailin ^a   Bisht, Kavita ^a,c   Feizi, Alborz ^a   Otterbein, Sherrie ^d   Zuckerbraun, Brian ^d   Costa, Daniel B ^a   Pandolfi, Pier Paolo ^a   Fillinger, Janos ^b   Döme, Balazs ^b,e,f   Otterbein, Leo E ^a   Wegiel, Barbara ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

^c GRIFFITH UNIVERSITY   (Australia)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Carbon monoxide; Immunotherapy; Macrophages; Tumor microenvironment

Indexed keywords

CARBON MONOXIDE; CD86 ANTIGEN; HEME OXYGENASE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYC PROTEIN; NOTCH1 RECEPTOR; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; CD86 PROTEIN, HUMAN; HMOX1 PROTEIN, HUMAN; MAPK1 PROTEIN, HUMAN; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL POLARITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LUNG CANCER; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; LUNG TUMOR; MACROPHAGE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; B7-2 ANTIGEN; BIOMARKERS, TUMOR; CARBON MONOXIDE; CELL PROLIFERATION; CELLS, CULTURED; HEME OXYGENASE-1; HUMANS; LUNG NEOPLASMS; MACROPHAGES; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84966593316     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8081     Document Type: Article

References (48)

1. Mizuguchi S, Stephen J, Bihari R, Markovic N, Suehiro S, Capretta A, Potter RF and Cepinskas G. CORM-3-derived CO modulates polymorphonuclear leukocyte migration across the vascular endothelium by reducing levels of cell surface-bound elastase. American journal of physiology Heart and circulatory physiology. 2009; 297:H920-929.
2. Wegiel B, Hedblom A, Li M, Gallo D, Csizmadia E, Harris C, Nemeth Z, Zuckerbraun BS, Soares M, Persson JL and Otterbein LE. Heme oxygenase-1 derived carbon monoxide permits maturation of myeloid cells. Cell Death Dis. 2014; 5:e1139.
3. Wegiel B, Hanto DW and Otterbein LE. The social network of carbon monoxide in medicine. Trends in molecular medicine. 2013; 19:3-11.
4. Elguero B, Gueron G, Giudice J, Toscani MA, De Luca P, Zalazar F, Coluccio-Leskow F, Meiss R, Navone N, De Siervi A and Vazquez E. Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation. Neoplasia. 2012; 14:1043-1056.
5. Nemeth Z, Li M, Csizmadia E, Dome B, Johansson M, Persson JL, Seth P, Otterbein L and Wegiel B. Heme oxygenase-1 in macrophages controls prostate cancer progression. Oncotarget. 2015; 6:33675-88. doi: 10.18632/oncotarget.5284.
6. Skrzypek K, Tertil M, Golda S, Ciesla M, Weglarczyk K, Collet G, Guichard A, Kozakowska M, Boczkowski J, Was H, Gil T, Kuzdzal J, Muchova L, Vitek L, Loboda A, Jozkowicz A, et al. Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. Antioxidants & redox signaling. 2013; 19:644-660.
7. Tertil M, Golda S, Skrzypek K, Florczyk U, Weglarczyk K, Kotlinowski J, Maleszewska M, Czauderna S, Pichon C, Kieda C, Jozkowicz A and Dulak J. Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases. Free radical biology & medicine. 2015; 89:147-157.
8. Wegiel B, Gallo D, Csizmadia E, Harris C, Belcher J, Vercellotti GM, Penacho N, Seth P, Sukhatme V, Ahmed A, Pandolfi PP, Helczynski L, Bjartell A, Persson JL and Otterbein LE. Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth. Cancer research. 2013; 73:7009-7021.
9. Chin BY, Jiang G, Wegiel B, Wang HJ, Macdonald T, Zhang XC, Gallo D, Cszimadia E, Bach FH, Lee PJ and Otterbein LE. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci U S A. 2007; 104:5109-5114.
10. Wegiel B, Larsen R, Gallo D, Chin BY, Harris C, Mannam P, Kaczmarek E, Lee PJ, Zuckerbraun BS, Flavell R, Soares MP and Otterbein LE. Macrophages sense and kill bacteria through carbon monoxide-dependent inflammasome activation. The Journal of clinical investigation. 2014; 124:4926-4940.
11. Hao NB, Lu MH, Fan YH, Cao YL, Zhang ZR and Yang SM. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol. 2012; 2012:948098.
12. Martinez FO, Sica A, Mantovani A and Locati M. Macrophage activation and polarization. Front Biosci. 2008; 13:453-461.
13. Mantovani A, Sozzani S, Locati M, Allavena P and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23:549-555.
14. Mosser DM and Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008; 8:958-969.
15. Gordon S and Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005; 5:953-964.
16. Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onoue H, Ito Y, Inamura T, Ikezaki K, Fukui M, Iwaki T and Kuwano M. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res. 1999; 5:1107-1113.
17. Boschetto P, Zeni E, Mazzetti L, Miotto D, Lo Cascio N, Maestrelli P, Marian E, Querzoli P, Pedriali M, Murer B, De Rosa E, Fabbri LM and Mapp CE. Decreased hemeoxygenase (HO)-1 in the macrophages of non-small cell lung cancer. Lung cancer. 2008; 59:192-197.
18. Wegiel B, Nemeth Z, Correa-Costa M, Bulmer AC and Otterbein LE. Heme oxygenase-1: a metabolic nike. Antioxidants & redox signaling. 2014; 20:1709-1722.
19. Vitek L, Gbelcova H, Muchova L, Vanova K, Zelenka J, Konickova R, Suk J, Zadinova M, Knejzlik Z, Ahmad S, Fujisawa T, Ahmed A and Ruml T. Antiproliferative effects of carbon monoxide on pancreatic cancer. Dig Liver Dis. 2014; 46:369-375.
20. Asano K, Nabeyama A, Miyake Y, Qiu CH, Kurita A, Tomura M, Kanagawa O, Fujii S and Tanaka M. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity. 2011; 34:85-95.
21. Weis N, Weigert A, von Knethen A and Brune B. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol Biol Cell. 2009; 20:1280-1288.
22. Florczyk U, Jazwa A, Maleszewska M, Mendel M, Szade K, Kozakowska M, Grochot-Przeczek A, Viscardi M, Czauderna S, Bukowska-Strakova K, Kotlinowski J, Jozkowicz A, Loboda A and Dulak J. Nrf2 regulates angiogenesis: effect on endothelial cells, bone marrowderived proangiogenic cells and hind limb ischemia. Antioxidants & redox signaling. 2014; 20:1693-1708.
23. Paine A, Eiz-Vesper B, Blasczyk R and Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochemical pharmacology. 2010; 80:1895-1903.
24. Franklin RA, Liao W, Sarkar A, Kim MV, Bivona MR, Liu K, Pamer EG and Li MO. The cellular and molecular origin of tumor-associated macrophages. Science. 2014; 344:921-925.
25. Palaga T, Buranaruk C, Rengpipat S, Fauq AH, Golde TE, Kaufmann SH and Osborne BA. Notch signaling is activated by TLR stimulation and regulates macrophage functions. Eur J Immunol. 2008; 38:174-183.
26. Cheng M, Wang D and Roussel MF. Expression of c-Myc in response to colony-stimulating factor-1 requires mitogenactivated protein kinase kinase-1. The Journal of biological chemistry. 1999; 274:6553-6558.
27. Pello OM, Chevre R, Laoui D, De Juan A, Lolo F, Andres-Manzano MJ, Serrano M, Van Ginderachter JA and Andres V. In vivo inhibition of c-MYC in myeloid cells impairs tumor-associated macrophage maturation and pro-tumoral activities. PloS one. 2012; 7:e45399.
28. Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, Sotomayor E, Padhya T, McCaffrey TV, McCaffrey JC and Gabrilovich DI. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol. 2009; 182:5693-5701.
29. Corzo CA, Condamine T, Lu L, Cotter MJ, Youn JI, Cheng P, Cho HI, Celis E, Quiceno DG, Padhya T, McCaffrey TV, McCaffrey JC and Gabrilovich DI. HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med. 2010; 207:2439-2453.
30. Chaturvedi P, Gilkes DM, Takano N and Semenza GL. Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment. Proc Natl Acad Sci U S A. 2014; 111:E2120-2129.
31. Zhang J, Cao J, Ma S, Dong R, Meng W, Ying M, Weng Q, Chen Z, Ma J, Fang Q, He Q and Yang B. Tumor hypoxia enhances Non-Small Cell Lung Cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling. Oncotarget. 2014; 5:9664-9677. doi: 10.18632/oncotarget.1856.
32. Yu L and Hales CA. Long-term exposure to hypoxia inhibits tumor progression of lung cancer in rats and mice. BMC Cancer. 2011; 11:331.
33. Dey S, Sayers CM, Verginadis, II, Lehman SL, Cheng Y, Cerniglia GJ, Tuttle SW, Feldman MD, Zhang PJ, Fuchs SY, Diehl JA and Koumenis C. ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. The Journal of clinical investigation. 2015; 125:2592-2608.
34. Zhang W, Xu W and Xiong S. Blockade of Notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. Journal of immunology. 2010; 184:6465-6478.
35. He H, Zhang S, Tighe S, Son J and Tseng SC. Immobilized heavy chain-hyaluronic acid polarizes lipopolysaccharideactivated macrophages toward M2 phenotype. The Journal of biological chemistry. 2013; 288:25792-25803.
36. Choi KM, Kashyap PC, Dutta N, Stoltz GJ, Ordog T, Shea Donohue T, Bauer AJ, Linden DR, Szurszewski JH, Gibbons SJ and Farrugia G. CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice. Gastroenterology. 2010; 138:2399-2409, 2409 e2391.
37. Sierra-Filardi E, Vega MA, Sanchez-Mateos P, Corbi AL and Puig-Kroger A. Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPSinduced IL-10 release. Immunobiology. 2010; 215:788-795.
38. Zuckerbraun BS, Billiar TR, Otterbein SL, Kim PK, Liu F, Choi AM, Bach FH and Otterbein LE. Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. The Journal of experimental medicine. 2003; 198:1707-1716.
39. Morita T, Perrella MA, Lee ME and Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci U S A. 1995; 92:1475-1479.
40. Hartsfield CL, Alam J, Cook JL and Choi AM. Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. Am J Physiol. 1997; 273:L980-988.
41. Martins VC, Busch K, Juraeva D, Blum C, Ludwig C, Rasche V, Lasitschka F, Mastitsky SE, Brors B, Hielscher T, Fehling HJ and Rodewald HR. Cell competition is a tumour suppressor mechanism in the thymus. Nature. 2014; 509:465-470.
42. Chen T, Meng Z, Gan Y, Wang X, Xu F, Gu Y, Xu X, Tang J, Zhou H, Zhang X, Gan X, Van Ness C, Xu G, Huang L, Zhang X, Fang Y, et al. The viral oncogene Np9 acts as a critical molecular switch for co-activating betacatenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells. Leukemia. 2013; 27:1469-1478.
43. Palomero T and Ferrando A. Oncogenic NOTCH1 control of MYC and PI3K: challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas. Clinical cancer research. 2008; 14:5314-5317.
44. Xu J, Chi F, Guo T, Punj V, Lee WN, French SW and Tsukamoto H. NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation. The Journal of clinical investigation. 2015; 125:1579-1590.
45. Boopathy AV, Pendergrass KD, Che PL, Yoon YS and Davis ME. Oxidative stress-induced Notch1 signaling promotes cardiogenic gene expression in mesenchymal stem cells. Stem cell research & therapy. 2013; 4:43.
46. Mo JS, Yoon JH, Ann EJ, Ahn JS, Baek HJ, Lee HJ, Kim SH, Kim YD, Kim MY and Park HS. Notch1 modulates oxidative stress induced cell death through suppression of apoptosis signal-regulating kinase 1. Proc Natl Acad Sci U S A. 2013; 110:6865-6870.
47. Wegiel B, Baty CJ, Gallo D, Csizmadia E, Scott JR, Akhavan A, Chin BY, Kaczmarek E, Alam J, Bach FH, Zuckerbraun BS and Otterbein LE. Cell surface biliverdin reductase mediates biliverdin-induced antiinflammatory effects via phosphatidylinositol 3-kinase and Akt. The Journal of biological chemistry. 2009; 284:21369-21378.
48. Otterbein LE, Hedblom A, Harris C, Csizmadia E, Gallo D and Wegiel B. Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxia-telangiectasia mutated (ATM) protein. Proc Natl Acad Sci U S A. 108:14491-14496.